• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Prenatal medication for opioid use disorder helps discharge infants back to mothers

byNancy LuandAvneesh Bhangu
April 22, 2022
in Chronic Disease, Pediatrics, Wellness
Reading Time: 2 mins read
Prenatal antidepressant exposure may increase risk of poor motor development
Share on FacebookShare on Twitter

1. In this study, medication prescribed for opioid use disorder amongst pregnant women often allowed newborn infants to be discharged to their parents, rather than relatives or foster care.

2. However, more than half of eligible women in this study did not receive medication for opioid use disorder.

Evidence Rating Level: 3 (Average)

Opioid use during pregnancy has increased steadily since the 2000s in the United States and remains a serious issue with no clear answer. Opioid use during pregnancy can lead to several adverse events including maternal adverse events as well as neonatal opioid withdrawal syndrome (NOWS). Medication for opioid use disorder (MOUD) is the standard treatment for opioid use disorder, includes medications such as methadone and buprenorphine. The purpose of this study was to identify maternal and neonatal factors associated with use of MOUD and determine the impact of receipt of MOUD on discharge to parents for infants born with NOWS.

This study used data from 3 Alaska, United States hospitals: Alaska Native Medical Center, Yukon Kuskokwim Delta Regional Hospital, and Fairbanks Memorial Hospital from July 2016-December 2019. From this dataset, only infants born with NOWS as defined by the Finnegan Neonatal Abstinence Scoring System were included (n=193). Infants were excluded if they were <36 weeks gestation or had any major birth defects. MOUD, whether the infant was discharged home to parents, maternal and perinatal care characteristics were recorded.

The results demonstrated that receiving MOUD during pregnancy increased the odds of an infant with NOWS being discharged home to parents by 4 times, indicating that MOUD during pregnancy may help keep families together. However, more than half of the mothers did not receive MOUD in this study, indicating need for greater access. However, this study was limited, as its relatively small sample size, and selective inclusion of clinics in Alaska. Despite these limitations, the results suggest that MOUD during pregnancy may help keep families together during discharge planning.

RELATED REPORTS

Methadone initiation linked to lower mortality compared to buprenorphine-naloxone after opioid overdose

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

Click to read the study in Journal of Addiction Medicine

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: babyinfantneonatalopioid use disorderpregnancywellness
Previous Post

Elevated neutrophil-lymphocyte ratio associated with poor prognosis for head and neck cancer

Next Post

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

RelatedReports

Chronic Disease

Methadone initiation linked to lower mortality compared to buprenorphine-naloxone after opioid overdose

September 7, 2026
Behavioral dysregulation in infancy predicts later child mental health
Imaging and Intervention

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

July 23, 2026
Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

May 6, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: TikTok “Fibermaxxing” trend targets gut microbiome diversity, Jennifer Aniston’s “Strength for 50+” ritual spotlights photobiomodulation, American Lung Association issues respiratory warning over viral “mouth taping” fad, and Psychiatric Times highlights initiative to close the schizophrenia mortality gap

April 22, 2026
Next Post
Nonpowder gun-related pediatric eye injuries on the rise

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Vaccination leads to a small absolute risk for shoulder conditions

Patient Basics: Hair Loss

Baricitinib is superior to placebo for treatment of alopecia areata

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes
  • 2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances
  • Aletta brings autonomous robotics into routine blood collection
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in